Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Cash Flow-to-Debt Ratio
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥294.76 Million could theoretically repay 0% of its total liabilities (CN¥3.00 Billion) in one year. See 002424 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Guizhou Bailing Group Pharmaceutical Co Ltd across 19 annual periods. Also explore 002424 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Guizhou Bailing Group Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market cap of Guizhou Bailing Group Pharmaceutical Co .
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥748.72 Million | CN¥3.02 Billion | ▲ +10707.0% |
| 2024 | 0.00x | CN¥9.02 Million | CN¥3.94 Billion | ▼ -93.0% |
| 2023 | 0.03x | CN¥125.77 Million | CN¥3.82 Billion | ▼ -81.0% |
| 2022 | 0.17x | CN¥502.15 Million | CN¥2.90 Billion | ▲ +34.9% |
| 2021 | 0.13x | CN¥324.92 Million | CN¥2.53 Billion | ▲ +72.5% |
| 2020 | 0.07x | CN¥231.78 Million | CN¥3.11 Billion | ▼ -53.6% |
| 2019 | 0.16x | CN¥467.41 Million | CN¥2.91 Billion | ▲ +309.1% |
| 2018 | -0.08x | CN¥-157.45 Million | CN¥2.05 Billion | ▼ -230.2% |
| 2017 | 0.06x | CN¥79.88 Million | CN¥1.36 Billion | ▼ -85.2% |
| 2016 | 0.40x | CN¥466.62 Million | CN¥1.17 Billion | ▲ +11.9% |
| 2015 | 0.36x | CN¥413.23 Million | CN¥1.16 Billion | ▲ +9.5% |
| 2014 | 0.33x | CN¥395.83 Million | CN¥1.22 Billion | ▲ +210.1% |
| 2013 | 0.10x | CN¥141.76 Million | CN¥1.35 Billion | ▲ +543.4% |
| 2012 | 0.02x | CN¥19.52 Million | CN¥1.20 Billion | ▼ -91.3% |
| 2011 | 0.19x | CN¥201.90 Million | CN¥1.08 Billion | ▲ +139.8% |
| 2010 | -0.47x | CN¥-447.68 Million | CN¥952.49 Million | ▼ -267.1% |
| 2009 | 0.28x | CN¥125.31 Million | CN¥445.48 Million | ▲ +323.2% |
| 2008 | -0.13x | CN¥-40.42 Million | CN¥320.72 Million | ▲ +49.8% |
| 2007 | -0.25x | CN¥-79.37 Million | CN¥315.87 Million | — |